An Unusual Case of Granulomatous Lung Disease

Abstract

 

This is a preview of subscription content, log in to check access.

Fig 1
Fig 2
Fig 3
Fig 4

References

  1. 1.

    Thatayatikom A, Thatayatikom S, White, AJ (2005) Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immun 95:293–300

    Article  Google Scholar 

  2. 2.

    Lukela M, DeGuzman D, Weinberger S, et al. (2005) Clinical problem-solving. Unfashionably late. N Engl J Med 352:64–69

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Shmerling RH, Delbanco TL (1991) The rheumatoid factor: an analysis of clinical utility. Am J Med 91:528–534

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    du Bois RM, Wells AU (2003) The lung in rheumatic diseases. In: Hochberg MC, Silman AJ, Smolen JS, et al. (eds) Rheumatology, 3rd edn. Mosby, New York, pp 315–323

    Google Scholar 

  5. 5.

    Keystone EC (2004) The utility of tumour necrosis factor blockade in orphan diseases. Ann Rheum Dis 63(Suppl 2):ii79–ii83

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Baughman RP (2004) Pulmonary sarcoidosis. Clin Chest Med 25:521–530

    PubMed  Article  Google Scholar 

  7. 7.

    Baughman RP, Lower EE (2001) Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:70–74

    PubMed  CAS  Google Scholar 

  8. 8.

    Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064–1071

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Gill KR, Mahadevan U (2005) Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease. Inflamm Bowel Dis 11:210–212

    PubMed  Article  Google Scholar 

  10. 10.

    Roberts SD, Wilkes DS, Burgett RA, et al. (2003) Refractory sarcoidosis responding to infliximab. Chest 124:2028–2031

    PubMed  Article  Google Scholar 

  11. 11.

    Ulbricht KU, Stoll M, Bierwirth J, et al. (2003) Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 48:3542–3543

    PubMed  Article  Google Scholar 

  12. 12.

    Yee AM, Pochapin MB (2001) Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27–31

    PubMed  CAS  Google Scholar 

  13. 13.

    Moller DR (2003) Treatment of sarcoidosis—from a basic science point of view. J Intern Med 253:31–40

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Sandborn WJ, Hanauer SB, Katz S, et al. (2001) Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 121:1088–1094

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Utz JP, Limper AH, Kalra S, et al. (2003) Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124:177–185

    PubMed  Article  CAS  Google Scholar 

  16. 16.

    The WGET Research Group (2005) Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 352:351–361

    Article  Google Scholar 

  17. 17.

    Khanna D, McMahon M, Furst DE (2004) Safety of tumour necrosis factor-alpha antagonists. Drug Safety 27:307–324

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Callejas-Rubio JL, Ortego-Centeno N, Lopez-Perez L, et al. (2005) Treatment of therapy-resistant sarcoidosis with adalimumab. Clin Rheumatol 1–2

Download references

Acknowledgments

The authors would like to thank Drs. Gordon Gamsu and Thomas King for their presentations and helpful discussions regarding this case, and Dr. C. Ronald MacKenzie for critical review of the manuscript.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Deborah Alpert MD, PhD.

Additional information

A Clinical Pathology Conference Held by Hospital for Special Surgery and Weill Medical College of Cornell University.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Alpert, D., Flieder, D.B., Erkan, D. et al. An Unusual Case of Granulomatous Lung Disease. HSS Jrnl 2, 191–197 (2006). https://doi.org/10.1007/s11420-006-9009-0

Download citation

Key words

  • granuloma
  • lung disease
  • tumor necrosis factor alpha inhibitor